• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
    • Sports
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • Trump Administration
  • IN FOCUS
  • Opinion
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism & Unity
    • Faith, Freedom & Self-Reliance
    • Courage, Strength & Optimism
    • Equality, Not Elitism
    • Community & Family
    • Fairness & Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Authors Posts by Linda Johnson

    Linda Johnson

    FDA staff: J&J diabetes drug may pose heart risk
    Business

    FDA staff: J&J diabetes drug may pose heart risk

    Linda Johnson -
    January 8, 2013 9:40 pm
    0
    Bristol-Myers, Pfizer’s Eliquis approved in Japan
    Business

    Bristol-Myers, Pfizer’s Eliquis approved in Japan

    Linda Johnson -
    December 26, 2012 6:55 pm
    0
    Amgen buying deCODE Genetics for $415 million
    Business

    Amgen buying deCODE Genetics for $415 million

    Linda Johnson -
    December 10, 2012 9:30 pm
    0
      This undated image provided by Merck & Co., shows a cross section of a normal brain (right) and one of a brain damaged by advanced Alzheimer's disease. Alzheimer's patients and their families, desperate for an effective treatment for the epidemic disease, there's hope from new studies starting up and insights from recent ones that didn't quite pan out. (AP Photo/Merck & Co.)
    Business

    New Alzheimer’s drug studies offer patients hope

    Linda Johnson -
    December 3, 2012 4:55 pm
    0
    New Alzheimer’s drug studies offer patients hope
    News

    New Alzheimer’s drug studies offer patients hope

    Linda Johnson -
    December 3, 2012 11:47 am
    0
    Drugmaker Ranbaxy halts generic Lipitor production
    Business

    Drugmaker Ranbaxy halts generic Lipitor production

    Linda Johnson -
    November 30, 2012 10:49 pm
    0
    Ranbaxy recalls generic Lipitor doses
    Business

    Ranbaxy recalls generic Lipitor doses

    Linda Johnson -
    November 23, 2012 5:45 pm
    0
    Bristol-Pfizer anticlot drug gets key EU approval
    Business

    Bristol-Pfizer anticlot drug gets key EU approval

    Linda Johnson -
    November 20, 2012 10:33 pm
    0
    Pfizer: Long-acting Lyrica better than placebo
    Business

    Pfizer: Long-acting Lyrica better than placebo

    Linda Johnson -
    November 19, 2012 9:45 pm
    0
    Drugmakers collaborate to facilitate drug tests
    Business

    Drugmakers collaborate to facilitate drug tests

    Linda Johnson -
    November 15, 2012 2:20 pm
    0
    1...8910...12Page 9 of 12
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism & Unity
    • Faith, Freedom & Self-Reliance
    • Courage, Strength & Optimism
    • Equality, Not Elitism
    • Community & Family
    • Fairness & Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter